In this week's Pharma Pulse, Trump nominates Heidi Overton to lead the FDA, EVERSANA expands its AI-powered commercialization ...

Cardinal Health's Michelle Britt discusses the operating costs, cash flow strain and reimbursement pressures facing ...

Trump is expected to pick White House aide Dr. Heidi Overton to lead the FDA, pending Senate confirmation, as the agency works to rebuild industry trust. Overton is among three finalists for the role, ...

AI in PV can compress the interval between signal observation and documented action, preserving benefit–risk integrity and ...

TrumpRx was launched as a White House most-favored-nation pricing vehicle, initially listing cash-pay discounts from five manufacturers and expanding participating products and companies over time.

EVERSANA's Vikram Anand breaks down FDA data on complete response letters, showing how gaps in pharmacovigilance and safety readiness, not manufacturing alone, drive costly delays in drug ...

EVERSANA's Vikram Anand breaks down FDA data on complete response letters, showing how gaps in pharmacovigilance and safety readiness, not manufacturing alone, drive costly delays in drug ...

Kuala Lumpur’s GDP-certified capability supports both active and passive temperature-controlled pharma logistics, spanning vaccines, biotech therapeutics, and diagnostic specimens requiring validated ...

Separating the combination MMR shot into three vaccines would not just change how children are immunized. It would require building three new supply chains from a licensing base that does not yet ...

In this week's Pharma Pulse, Eli Lilly sues companies over black-market retatrutide sales, Bristol Myers Squibb commits $2.3 billion to a new Houston manufacturing campus, and FDA opens an assessment ...